Earnings per share is a fundamental indicator that investors use to evaluate a company and decide which investments to make. It displays how much profits a company is making on each share. Every quarter, the corporation divides its net income by
Broking firm Sharekhan is bullish on the stock of PowerGrid and has recommended buying the stock for near 30% gains from the current levels. The brokerage has set a target price of Rs 265 on the stock of the Maharatna company.
The markets have turned exceedingly volatile in the last few trading sessions. It maybe a good time to buy stocks ahead of the festive season, as some from the auto sector could benefit. Sharekhan has recommended buying select auto stocks from
The bearish sentiments in the Indian market continue, and India's benchmark indices have again closed negative in the most recent trading session. The Indian markets will be driven by the news today as the announcement of the new RBI monetary policy
Anand Rathi, a leading brokerage firm, has given a "buy" rating to  for a target price of Rs 1,724 apiece. Torrent Pharmaceuticals is a large cap pharmaceuticals company. It has a market capitalization of Rs 52.316.90 crore. Torrent Pharma, the flagship
Prabhudas Lilladher in its recent report on Westlife Development Ltd. recommended investors buy the stock for a target price of Rs 847 apiece. Westlife Development is a small cap tourism and Hospitality sector company having a market capitalisation of Rs 10,862.51
Leading brokerage firm Axis Securities is bullish on ITC Ltd. The brokerage has recommended "Buy" for an estimated target price of Rs 380 apiece. Considering the target price, and the Current Market Price, the stock is likely to surge 15% in
In a recent report on Motherson Sumi Wiring India Ltd. (MSWIL), ICICI Direct recommended "buy" for a target price of Rs. 105 per share. The stock is likely to surge by 24% in 12 months, given the estimated target price. MSWIL
Leading brokerage firm ICICI Direct in its recent report on Torrent Pharmaceuticals Ltd (Torrent Pharma). has rated the it "buy" with a target price of Rs 1730 apiece. Given the brokerage's predicted target price, investors who purchase the company's stocks at
Leading brokerage firm Motilal Oswal is suggesting buying the stock of Star Health and Allied Insurance Company. Star Health is focusing on deepening its presence in rural India, with the creation of a dedicated vertical for addressing a demand from these geographies.